120 related articles for article (PubMed ID: 3464432)
1. Analysis of nuclear m-AMSA content by DNA fluorochrome competition.
Andersson BS; Beran M; Barlogie B; Van NT; McCredie KB
Eur J Cancer Clin Oncol; 1986 Jul; 22(7):883-9. PubMed ID: 3464432
[TBL] [Abstract][Full Text] [Related]
2. Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin.
Zwelling LA; Michaels S; Erickson LC; Ungerleider RS; Nichols M; Kohn KW
Biochemistry; 1981 Nov; 20(23):6553-63. PubMed ID: 6895473
[TBL] [Abstract][Full Text] [Related]
3. The production of topoisomerase II-mediated DNA cleavage in human leukemia cells predicts their susceptibility to 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA).
Bakic M; Beran M; Andersson BS; Silberman L; Estey E; Zwelling LA
Biochem Biophys Res Commun; 1986 Jan; 134(2):638-45. PubMed ID: 3004458
[TBL] [Abstract][Full Text] [Related]
4. Cooperative sequestration of m-AMSA in L1210 cells.
Zwelling LA; Kerrigan D; Michaels S; Kohn KW
Biochem Pharmacol; 1982 Oct; 31(20):3269-77. PubMed ID: 6897359
[TBL] [Abstract][Full Text] [Related]
5. Cross-resistance of an amsacrine-resistant human leukemia line to topoisomerase II reactive DNA intercalating agents. Evidence for two topoisomerase II directed drug actions.
Zwelling LA; Mayes J; Hinds M; Chan D; Altschuler E; Carroll B; Parker E; Deisseroth K; Radcliffe A; Seligman M
Biochemistry; 1991 Apr; 30(16):4048-55. PubMed ID: 1850298
[TBL] [Abstract][Full Text] [Related]
6. Effect of 1-beta-D-arabinofuranosylcytosine (ara-C) on nuclear topoisomerase II activity and on the DNA cleavage and cytotoxicity produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and etoposide in m-AMSA-sensitive and -resistant human leukemia cells.
Bakic M; Chan D; Andersson BS; Beran M; Silberman L; Estey E; Ricketts L; Zwelling LA
Biochem Pharmacol; 1987 Dec; 36(23):4067-77. PubMed ID: 2825713
[TBL] [Abstract][Full Text] [Related]
7. Resistance to 4-(9-acridinylamino) methanesulphon-m-anisidide (m-AMSA) in human myeloid leukaemia.
Skinner WL; Murray D; Kohli V; Beran M; McCredie KB; Freireich EJ; Andersson BS
Br J Cancer; 1990 Jan; 61(1):51-5. PubMed ID: 2297490
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of resistance of noncycling mammalian cells to 4'-(9-acridinylamino)methanesulfon-m-anisidide: comparison of uptake, metabolism, and DNA breakage in log- and plateau-phase Chinese hamster fibroblast cell cultures.
Robbie MA; Baguley BC; Denny WA; Gavin JB; Wilson WR
Cancer Res; 1988 Jan; 48(2):310-9. PubMed ID: 2825971
[TBL] [Abstract][Full Text] [Related]
9. Effect of cell proliferation and chromatin conformation on intercalator-induced, protein-associated DNA cleavage in human brain tumor cells and human fibroblasts.
Zwelling LA; Estey E; Silberman L; Doyle S; Hittelman W
Cancer Res; 1987 Jan; 47(1):251-7. PubMed ID: 3024817
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic action and cell cycle effects of ALGA, a peptidic derivative of the antileukemic drug amsacrine.
Collyn-d'Hooghe M; Bernier JL; Henichart JP
Cancer Biochem Biophys; 1987 Sep; 9(3):257-64. PubMed ID: 3435897
[TBL] [Abstract][Full Text] [Related]
11. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
de Jong S; Kooistra AJ; de Vries EG; Mulder NH; Zijlstra JG
Cancer Res; 1993 Mar; 53(5):1064-71. PubMed ID: 8382551
[TBL] [Abstract][Full Text] [Related]
12. Interaction of the antitumour drug 4'-(9-acridinylamino)-methanesulfon-m-anisidine.HCl (m-AMSA) with nucleic acids.
Hudecz F; Kajtár J; Szekerke M
Nucleic Acids Res; 1981 Dec; 9(24):6959-73. PubMed ID: 6174949
[TBL] [Abstract][Full Text] [Related]
13. Modulation of 4'-(9-acridinylamino)methanesulfon-m-anisidide-induced, topoisomerase II-mediated DNA cleavage by gossypol.
Adlakha RC; Ashorn CL; Chan D; Zwelling LA
Cancer Res; 1989 Apr; 49(8):2052-8. PubMed ID: 2539251
[TBL] [Abstract][Full Text] [Related]
14. The interaction between nuclear topoisomerase II activity from human leukemia cells, exogenous DNA, and 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) or 4-(4,6-O-ethylidene-beta-D-glucopyranoside) (VP-16) indicates the sensitivity of the cells to the drugs.
Estey EH; Silberman L; Beran M; Andersson BS; Zwelling LA
Biochem Biophys Res Commun; 1987 Apr; 144(2):787-93. PubMed ID: 3034264
[TBL] [Abstract][Full Text] [Related]
15. Intercalator-induced, topoisomerase II-mediated DNA cleavage and its modification by antineoplastic antimetabolites.
Zwelling LA; Silberman L; Estey E
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1041-7. PubMed ID: 2427489
[TBL] [Abstract][Full Text] [Related]
16. Effect of polyamine depletion by alpha-difluoromethylornithine or (2R,5R)-6-heptyne-2,5-diamine on drug-induced topoisomerase II-mediated DNA cleavage and cytotoxicity in human and murine leukemia cells.
Bakic M; Chan D; Freireich EJ; Marton LJ; Zwelling LA
Cancer Res; 1987 Dec; 47(24 Pt 1):6437-43. PubMed ID: 2824033
[TBL] [Abstract][Full Text] [Related]
17. Absence of swiveling at sites of intercalator-induced protein-associated deoxyribonucleic acid strand breaks in mammalian cell nucleoids.
Pommier Y; Mattern MR; Schwartz RE; Zwelling LA
Biochemistry; 1984 Jun; 23(13):2922-7. PubMed ID: 6547848
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity and resistance to chemotherapy in acute leukemia: correlation with in vitro drug uptake and lack of potentiation by verapamil.
Andersson BS; Beran M; Stuckey SE; McCredie KB; Mavligit GM
Med Oncol Tumor Pharmacother; 1987; 4(1):17-21. PubMed ID: 3600053
[TBL] [Abstract][Full Text] [Related]
19. Effects of DNA intercalating agents on topoisomerase II induced DNA strand cleavage in isolated mammalian cell nuclei.
Pommier Y; Schwartz RE; Zwelling LA; Kohn KW
Biochemistry; 1985 Nov; 24(23):6406-10. PubMed ID: 3002439
[TBL] [Abstract][Full Text] [Related]
20. In vitro toxicity and DNA cleaving capacity of benzisoquinolinedione (nafidimide; NSC 308847) in human leukemia.
Andersson BS; Beran M; Bakic M; Silberman LE; Newman RA; Zwelling LA
Cancer Res; 1987 Feb; 47(4):1040-4. PubMed ID: 3026621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
